Out-of-field Doses from Radiotherapy Using Photon Beams: A Comparative Study for a Pediatric Renal Treatment

Overview

Journal J Appl Clin Med Phys

Specialties Biophysics
General Medicine

Date 2021 Feb 6

PMID 33547766

Citations 7

Authors

Julie Colnot

Sofia Zefkili

Regine Gschwind

Christelle Huet

Affiliations

Soon will be listed here.

Abstract

Purpose: First, this experimental study aims at comparing out-of-field doses delivered by three radiotherapy techniques (3DCRT, VMAT (two different accelerators), and tomotherapy) for a pediatric renal treatment. Secondly, the accuracy of treatment planning systems (TPS) for out-of-field calculation is evaluated.

Methods: EBT3 films were positioned in pediatric phantoms (5 and 10 yr old). They were irradiated according to four plans: 3DCRT (Clinac 2100CS, Varian), VMAT (Clinac 2100CS and Halcyon, Varian), and tomotherapy for a same target volume. 3D dose determination was performed with an in-house Matlab tool using linear interpolation of film measurements. 1D and 3D comparisons were made between techniques. Finally, measurements were compared to the Eclipse (Varian) and Tomotherapy (Accuray) TPS calculations.

Results: Advanced radiotherapy techniques (VMATs and tomotherapy) deliver higher out-of-field doses compared to 3DCRT due to increased beam-on time triggered by intensity modulation. Differences increase with distance to target and reach a factor of 3 between VMAT and 3DCRT. Besides, tomotherapy delivers lower doses than VMAT: although tomotherapy beam-on time is higher than in VMAT, the additional shielding of the Hi-Art system reduces out-of-field doses. The latest generation Halcyon system proves to deliver lower peripheral doses than conventional accelerators. Regarding TPS calculation, tomotherapy proves to be suitable for out-of-field dose determination up to 30 cm from field edge whereas Eclipse (AAA and AXB) largely underestimates those doses.

Conclusion: This study shows that the high dose conformation allowed by advanced radiotherapy is done at the cost of higher peripheral doses. In the context of treatment-related risk estimation, the consequence of this increase might be significative. Modern systems require adapted head shielding and a particular attention has to be taken regarding on-board imaging dose. Finally, TPS advanced dose calculation algorithms do not certify dose accuracy beyond field edges, and thus, those doses are not suitable for risk assessment.

Citing Articles

A comprehensive Study of the Out of Field Non Target Dose Associated with 6 and 10 MV Flattened and Flattening Filter Free X Ray Beam in a True Beam Linear Accelerator.

Athiyaman H, Anbu G, Mayilvaganan A, Chougule A, Sharma N, Kumar H Asian Pac J Cancer Prev. 2024; 25(5):1529-1538.

PMID: 38809624 PMC: 11318832. DOI: 10.31557/APJCP.2024.25.5.1529.

Analytical models for external photon beam radiotherapy out-of-field dose calculation: a scoping review.

Benzazon N, Colnot J, de Kermenguy F, Achkar S, De Vathaire F, Deutsch E Front Oncol. 2023; 13:1197079.

PMID: 37228501 PMC: 10203488. DOI: 10.3389/fonc.2023.1197079.

Accuracy and reliability of a commercial treatment planning system in nontarget regions in modern prostate radiotherapy.

Danckaert W, Ost P, De Wagter C J Appl Clin Med Phys. 2023; 24(8):e14003.

PMID: 37170654 PMC: 10402685. DOI: 10.1002/acm2.14003.

Comparison of 3DCRT and IMRT out-of-field doses in pediatric patients using Monte Carlo simulations with treatment planning system calculations and measurements.

Sa A, Barateiro A, Bednarz B, Almeida P, Vaz P, Madaleno T Front Oncol. 2022; 12:879167.

PMID: 35992845 PMC: 9388939. DOI: 10.3389/fonc.2022.879167.

Semi-experimental assessment of neutron equivalent dose and secondary cancer risk for off-field organs in glioma patients undergoing 18-MV radiotherapy.

Elmtalab S, Abedi I, Alirezaei Z, Choopan Dastjerdi M, Geraily G, Karimi A PLoS One. 2022; 17(7):e0271028.

PMID: 35905102 PMC: 9337694. DOI: 10.1371/journal.pone.0271028.

References

Manabe Y, Shibamoto Y, Sugie C, Hayashi A, Murai T, Yanagi T . Helical and Static-port Tomotherapy Using the Newly-developed Dynamic Jaws Technology for Lung Cancer. Technol Cancer Res Treat. 2014; 14(5):583-91. PMC: 4639908. DOI: 10.7785/tcrtexpress.2013.600280. View

Papanikolaou N, Mackie T, Gehring M, Reckwerdt P . Investigation of the convolution method for polyenergetic spectra. Med Phys. 1993; 20(5):1327-36. DOI: 10.1118/1.597154. View

Jeraj R, Mackie T, Balog J, Olivera G, Pearson D, Kapatoes J . Radiation characteristics of helical tomotherapy. Med Phys. 2004; 31(2):396-404. DOI: 10.1118/1.1639148. View

Howell R, Scarboro S, Taddei P, Krishnan S, Kry S, Newhauser W . Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy. Phys Med Biol. 2010; 55(23):7009-23. PMC: 3001332. DOI: 10.1088/0031-9155/55/23/S04. View

Ding G, Alaei P, Curran B, Flynn R, Gossman M, Mackie T . Image guidance doses delivered during radiotherapy: Quantification, management, and reduction: Report of the AAPM Therapy Physics Committee Task Group 180. Med Phys. 2018; 45(5):e84-e99. DOI: 10.1002/mp.12824. View

Kry S, Salehpour M, Followill D, Stovall M, Kuban D, White R . Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005; 62(4):1204-16. DOI: 10.1016/j.ijrobp.2004.12.091. View

Villarreal-Barajas J, Khan R . Energy response of EBT3 radiochromic films: implications for dosimetry in kilovoltage range. J Appl Clin Med Phys. 2014; 15(1):4439. PMC: 5711253. DOI: 10.1120/jacmp.v15i1.4439. View

Travis L, Ng A, Allan J, Pui C, Kennedy A, Xu X . Second malignant neoplasms and cardiovascular disease following radiotherapy. J Natl Cancer Inst. 2012; 104(5):357-70. PMC: 3295744. DOI: 10.1093/jnci/djr533. View

Mackie T, SCRIMGER J, Battista J . A convolution method of calculating dose for 15-MV x rays. Med Phys. 1985; 12(2):188-96. DOI: 10.1118/1.595774. View

10.

Joosten A, Bochud F, Baechler S, Levi F, Mirimanoff R, Moeckli R . Variability of a peripheral dose among various linac geometries for second cancer risk assessment. Phys Med Biol. 2011; 56(16):5131-51. DOI: 10.1088/0031-9155/56/16/004. View

11.

Miller K, Siegel R, Lin C, Mariotto A, Kramer J, Rowland J . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016; 66(4):271-89. DOI: 10.3322/caac.21349. View

12.

Wang B, Xu X . Measurements of non-target organ doses using MOSFET dosemeters for selected IMRT and 3D CRT radiation treatment procedures. Radiat Prot Dosimetry. 2007; 128(3):336-42. DOI: 10.1093/rpd/ncm363. View

13.

Schneider U, Halg R, Hartmann M, Mack A, Storelli F, Joosten A . Accuracy of out-of-field dose calculation of tomotherapy and cyberknife treatment planning systems: a dosimetric study. Z Med Phys. 2013; 24(3):211-5. DOI: 10.1016/j.zemedi.2013.10.008. View

14.

Nagata H, Sugimoto S, Hongo H, Hashimoto H, Sato Y, Kawabata T . Patient organ doses from megavoltage computed tomography delivery with a helical tomotherapy unit using a general treatment planning system. J Radiat Res. 2019; 60(3):401-411. PMC: 6530616. DOI: 10.1093/jrr/rrz005. View

15.

Wang L, Ding G . The accuracy of the out-of-field dose calculations using a model based algorithm in a commercial treatment planning system. Phys Med Biol. 2014; 59(13):N113-28. DOI: 10.1088/0031-9155/59/13/N113. View

16.

Wang L, Ding G . Estimating the uncertainty of calculated out-of-field organ dose from a commercial treatment planning system. J Appl Clin Med Phys. 2018; 19(4):319-324. PMC: 6036345. DOI: 10.1002/acm2.12367. View

17.

Lloyd S, Lim T, Fave X, Flores-Martinez E, Atwood T, Moiseenko V . TG-51 reference dosimetry for the Halcyon™: A clinical experience. J Appl Clin Med Phys. 2018; 19(4):98-102. PMC: 6036354. DOI: 10.1002/acm2.12349. View

18.

Colnot J, Barraux V, Loiseau C, Berejny P, Batalla A, Gschwind R . A new Monte Carlo model of a Cyberknife system for the precise determination of out-of-field doses. Phys Med Biol. 2019; 64(19):195008. DOI: 10.1088/1361-6560/ab38e5. View

19.

Casanova Borca V, Pasquino M, Russo G, Grosso P, Cante D, Sciacero P . Dosimetric characterization and use of GAFCHROMIC EBT3 film for IMRT dose verification. J Appl Clin Med Phys. 2013; 14(2):4111. PMC: 5714357. DOI: 10.1120/jacmp.v14i2.4111. View

20.

Shah A, Langen K, Ruchala K, Cox A, Kupelian P, Meeks S . Patient dose from megavoltage computed tomography imaging. Int J Radiat Oncol Biol Phys. 2008; 70(5):1579-87. DOI: 10.1016/j.ijrobp.2007.11.048. View